Literature DB >> 17454446

Influenza A virus transactivates the mouse envelope gene encoding syncytin B and its regulator, glial cells missing 1.

Linnéa Asp1, Christoffer Nellåker, Håkan Karlsson.   

Abstract

Recently, two candidate analogs for human syncytin, denoted syncytins A and B, were identified in the murine genome. These were found to have expression patterns and functions similar to human syncytin. In addition, the identification of glial cells missing (GCM)-binding motifs in putative promoter regions of the mouse syncytins imply analogous regulation. Transcriptional modulation of syncytin by exogenous agents was recently suggested by studies reporting transactivation of syncytin in human cell lines following virus infections. The authors report that influenza A virus infection increased the levels of transcripts encoding Gcm1 and syncytin B, but not syncytin A, in NIH-3T3 cells as well as in mouse primary neurons or glia. Overexpression of human GCM1 in NIH-3T3 cells resulted in increased levels of transcripts encoding syncytin B but not syncytin A. Systemic administration of neurotropic influenza A virus resulted in a neuronal infection and increased levels of Gcm1-encoding transcripts in brains of young mice. The mouse may therefore be useful for studies on the expression and function of endogenous retroviral envelope genes and transcription factors regulating their expression in the placenta and brain during physiological or pathological conditions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17454446     DOI: 10.1080/13550280601103125

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  34 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  An envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptor.

Authors:  J L Blond; D Lavillette; V Cheynet; O Bouton; G Oriol; S Chapel-Fernandes; B Mandrand; F Mallet; F L Cosset
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

3.  Downregulation of placental syncytin expression and abnormal protein localization in pre-eclampsia.

Authors:  X Lee; J C Keith; N Stumm; I Moutsatsos; J M McCoy; C P Crum; D Genest; D Chin; C Ehrenfels; R Pijnenborg; F A van Assche; S Mi
Journal:  Placenta       Date:  2001-11       Impact factor: 3.481

4.  glial cells missing: a binary switch between neuronal and glial determination in Drosophila.

Authors:  T Hosoya; K Takizawa; K Nitta; Y Hotta
Journal:  Cell       Date:  1995-09-22       Impact factor: 41.582

5.  glial cells missing: a genetic switch that controls glial versus neuronal fate.

Authors:  B W Jones; R D Fetter; G Tear; C S Goodman
Journal:  Cell       Date:  1995-09-22       Impact factor: 41.582

6.  Persistence of the influenza A/WSN/33 virus RNA at midbrain levels of immunodefective mice.

Authors:  F Aronsson; H Karlsson; H G Ljunggren; K Kristensson
Journal:  J Neurovirol       Date:  2001-04       Impact factor: 2.643

Review 7.  Transcription factors underlying the development and endocrine functions of the placenta.

Authors:  James C Cross; Lynn Anson-Cartwright; Ian C Scott
Journal:  Recent Prog Horm Res       Date:  2002

8.  Human endogenous retrovirus glycoprotein-mediated induction of redox reactants causes oligodendrocyte death and demyelination.

Authors:  Joseph M Antony; Guido van Marle; Wycliffe Opii; D Allan Butterfield; François Mallet; Voon Wee Yong; John L Wallace; Robert M Deacon; Kenneth Warren; Christopher Power
Journal:  Nat Neurosci       Date:  2004-09-26       Impact factor: 24.884

9.  The potential to induce glial differentiation is conserved between Drosophila and mammalian glial cells missing genes.

Authors:  Yasuno Iwasaki; Toshihiko Hosoya; Hirohide Takebayashi; Yasuhiro Ogawa; Yoshiki Hotta; Kazuhiro Ikenaka
Journal:  Development       Date:  2003-10-22       Impact factor: 6.868

10.  Pathogenesis of neurovirulent influenza A virus infection in mice. Route of entry of virus into brain determines infection of different populations of cells.

Authors:  M Reinacher; J Bonin; O Narayan; C Scholtissek
Journal:  Lab Invest       Date:  1983-12       Impact factor: 5.662

View more
  5 in total

1.  Neonatal infection with neurotropic influenza A virus induces the kynurenine pathway in early life and disrupts sensorimotor gating in adult Tap1-/- mice.

Authors:  Linnéa Asp; Maria Holtze; Susan B Powell; Håkan Karlsson; Sophie Erhardt
Journal:  Int J Neuropsychopharmacol       Date:  2009-07-17       Impact factor: 5.176

2.  Transcriptional derepression of the ERVWE1 locus following influenza A virus infection.

Authors:  Fang Li; Christoffer Nellåker; Sarven Sabunciyan; Robert H Yolken; Lorraine Jones-Brando; Anne-Sofie Johansson; Björn Owe-Larsson; Håkan Karlsson
Journal:  J Virol       Date:  2014-01-29       Impact factor: 5.103

3.  Behavioral disturbances in adult mice following neonatal virus infection or kynurenine treatment--role of brain kynurenic acid.

Authors:  Xi-Cong Liu; Maria Holtze; Susan B Powell; Niccolò Terrando; Markus K Larsson; Anna Persson; Sara K Olsson; Funda Orhan; Magdalena Kegel; Linnea Asp; Michel Goiny; Lilly Schwieler; Göran Engberg; Håkan Karlsson; Sophie Erhardt
Journal:  Brain Behav Immun       Date:  2013-10-17       Impact factor: 7.217

4.  The Role of Syncytin in Placental Angiogenesis and Fetal Growth.

Authors:  Ya-Nan Wang; Yixin Ye; Da Zhou; Ze-Wen Guo; Zhelei Xiong; Xing-Xing Gong; Shi-Wen Jiang; Haibin Chen
Journal:  Front Cell Dev Biol       Date:  2022-04-12

Review 5.  Schizophrenia and Influenza at the Centenary of the 1918-1919 Spanish Influenza Pandemic: Mechanisms of Psychosis Risk.

Authors:  Adrianna P Kępińska; Conrad O Iyegbe; Anthony C Vernon; Robert Yolken; Robin M Murray; Thomas A Pollak
Journal:  Front Psychiatry       Date:  2020-02-26       Impact factor: 4.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.